Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Breast Cancer Research and Treatment
|
July 1, 1988
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study
D Amoroso, P Pronzato, G Bertelli, et al.
Cancer
|
February 15, 1991
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial
M Merlano, R Corvo, G Margarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1988
Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study
M Merlano, R Rosso, M R Sertoli, et al.
The Laryngoscope
|
May 1, 1990
Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck
M Merlano, R Rosso, M R Sertoli, et al.
American Journal of Clinical Oncology
|
January 22, 2002
Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study
M Benasso, M Merlano, G Sanguineti, et al.
Journal of Cancer Research and Clinical Oncology
|
June 27, 2007
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer
O Guérin, P Formento, C Lo Nigro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
M Venturini, L Del Mastro, O Garrone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas
R Corvó, W Giaretti, G Sanguineti, et al.
British Journal of Cancer
|
May 31, 2012
Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
C Palmieri, B Rudraraju, M Monteverde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck
E Colella, M Merlano, F Blengio, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Breast Cancer Research and Treatment
|
July 1, 1988
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study
D Amoroso, P Pronzato, G Bertelli, et al.
Cancer
|
February 15, 1991
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial
M Merlano, R Corvo, G Margarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1988
Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study
M Merlano, R Rosso, M R Sertoli, et al.
The Laryngoscope
|
May 1, 1990
Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck
M Merlano, R Rosso, M R Sertoli, et al.
American Journal of Clinical Oncology
|
January 22, 2002
Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study
M Benasso, M Merlano, G Sanguineti, et al.
Journal of Cancer Research and Clinical Oncology
|
June 27, 2007
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer
O Guérin, P Formento, C Lo Nigro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
M Venturini, L Del Mastro, O Garrone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas
R Corvó, W Giaretti, G Sanguineti, et al.
British Journal of Cancer
|
May 31, 2012
Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
C Palmieri, B Rudraraju, M Monteverde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck
E Colella, M Merlano, F Blengio, et al.
Page
of 7